PALB2 and pancreatic neoplasm: Additionally, young-onset PC (in patients younger than 50 years old) shows higher proportions of MSI-high/dMMR, BRCA2-mutant, and PALB2-mutant tumors compared with patients with average-onset pancreatic cancer (70 years and older) [160].